Diagnosis and Management of the Cancer of the Uterus

Living reference work entry


Uterine cancer is the most common malignancy of the female genital tract. Treatment of uterine cancer is related to cell type, grade, and stage. However, the vast majority of uterine cancers will be low grade, early stage endometrial cancers with obesity being the primary risk factor associated with these cancers. Surgery is an important part of staging and management of uterine cancers.


Uterine cancer HNPCC Lynch syndrome Endometrial cancer Sarcoma Staging endometrial stromal cancer 


  1. Amant F, Floquet A, Friedlander M, Kristensen G, Mahner S, Nam EJ, Powell MA, Ray-Coquard I, Siddiqui N, Sykes P, Westermann AM, Seddon B. Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma. Int J Gynecol Cancer. 2014;24(9 Suppl 3):S67–72.CrossRefPubMedGoogle Scholar
  2. American College of Obstetricians and Gynecologists. Lynch syndrome. Practice Bulletin No. 147. Obstet Gynecol. 2014;124:1042–54.Google Scholar
  3. Cantrell LA, Havrilesky L, Moore DT, O’Malley D, Liotta M, Secord AA, Nagel CI, Cohn DE, Fader AN, Wallace AH, Rose P, Gehrig PA. A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma. Gynecol Oncol. 2012;127(1):22.CrossRefPubMedGoogle Scholar
  4. Cowden syndrome – Genetics Home Reference. 2014;1–7. http://ghr.nlm.nih.gov/condition/cowden-syndrome. Accessed 20 Jan 14.
  5. Creutzberg CL, van Putten WL, Koper PC, Lybert ML, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404–11.CrossRefPubMedGoogle Scholar
  6. D’Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2009;1–9. doi:10.1016/j.ygyno.2009.09.023.Google Scholar
  7. Decruze SB, Green JA. Hormone therapy in advanced and recurrent endometrial cancer: a systematic review. Int J Gynecol Cancer. 2007;17:964.CrossRefPubMedGoogle Scholar
  8. Fader AN, Drake RD, O’Malley DM, Gibbons HE, Huh WK, Havrilesky LJ, et al. Platinum/taxane based chemotherapy with or without radiotherapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer. 2009;115:2119–27.CrossRefPubMedGoogle Scholar
  9. Friedlander ML, Covens A, Glasspool RM, Hilpert F, Kristensen G, Kwon S, Selle F, Small W, Witteveen E, Russell P. Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract. Int J Gynecol Cancer. 2014;24(9 Suppl 3):S78–82.CrossRefPubMedGoogle Scholar
  10. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.20107.CrossRefPubMedGoogle Scholar
  11. Kapp DS, Shin JY, Chan JK. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer. 2008;112(4):820.CrossRefPubMedGoogle Scholar
  12. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, Pearlman A, Bell JG. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92(3):744–51.CrossRefPubMedGoogle Scholar
  13. Lau HY, Twu NF, Yen MS, Tsai HW, Wang PH, Chuang CM, Wu HH, Chao KC, Chen YJ. Impact of ovarian preservation in women with endometrial cancer. J Chin Med Assoc. 2014;77(7):379–84.CrossRefPubMedGoogle Scholar
  14. Lee TS, Lee JY, Kim JW, Oh S, Seong SJ, Lee JM, Kim TJ, Cho CH, Kim SM, Park CY. Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study. Gynecol Oncol. 2013;131(2):289–93.CrossRefPubMedGoogle Scholar
  15. Lynch syndrome – Genetics Home Reference. 2014;1–7. http://ghr.nlm.nih.gov/condition/lynch-syndrome. Accessed 20 Jan 14.Google Scholar
  16. Major FJ, Blessing JA, Silverberg SG, Morrow CP, Creasman WT, Currie JL, Yordan E, Brady MF. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer. 1993;71 Suppl 4:1702.CrossRefPubMedGoogle Scholar
  17. Mariani A, Sebo TJ, Katzmann JA, Keeney GL, Roche PC, Lesnick TG, Podratz KC. Pretreatment assessment of prognostic indicators in endometrial cancer. Am J Obstet Gynecol. 2000;182(6):1535–44.CrossRefPubMedGoogle Scholar
  18. Mutch DG. The new FIGO staging system for cancers of the vulva, cervix, endometrium, and sarcomas. Gynecol Oncol. 2009;115:325–8.CrossRefGoogle Scholar
  19. NCCN. Uterine Neoplasm. 2012;1–63.Google Scholar
  20. Omura GA, Blessing JA, Major F, Lifshitz S, Ehrlich CE, Mangan C, Beecham J, Park R, Silverberg S. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study. J Clin Oncol. 1985;3(9):1240.PubMedGoogle Scholar
  21. Pautier P, Nam EJ, Provencher DM, Hamilton AL, Mangili G, Siddiqui NA, Westermann AM, Reed NS, Harter P, Ray-Coquard I. Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus. Int J Gynecol Cancer. 2014;24(9 Suppl 3):S73–7.CrossRefPubMedGoogle Scholar
  22. Rauh-Hain JA, Growdon WB, Schorge JO, Goodman AK, Boruta DM, McCAnn C, et al. Prognsotic determinants in patients with stage IIIC-Iv uterine papillary serous carcinoma. Gynecol Oncol. 2010;119:299–304.CrossRefPubMedGoogle Scholar
  23. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78. doi:10.1016/S0140-6736(08)60269-X.CrossRefPubMedGoogle Scholar
  24. Retinoblastoma – Genetics Home Reference. 2014;1–4. http://ghr.nlm.nih.gov/condition/retinoblastoma. Accessed 20 Jan 14.
  25. Seamon LG, Cohn DE, Henretta MS, Kim KH, Carlson MJ, Phillips GS, Fowler JM. Minimally invasive comprehensive surgical staging for endometrial cancer: robotics or laparoscopy? Gynecol Oncol. 2009;113(1):36–41.CrossRefPubMedGoogle Scholar
  26. SEER. Cancer of the Endometrium – SEER Stat Fact Sheets. 2013. 1–10 http://seer.cancer.gov/statfacts/html/corp.html. Accessed 20 Jan 14.
  27. Sorosky JI. Endometrial cancer. Obstet Gynecol. 2012;120(2, Part 1):383–97. doi:10.1097/AOG.0b013e3182605bf1.CrossRefPubMedGoogle Scholar
  28. Tanner EJ, Leitao Jr MM, Garg K, Chi DS, Sonoda Y, Gardner GJ, Barakat RR, Jewell EL. The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma. Gynecol Oncol. 2011;123(3):548–52.CrossRefPubMedGoogle Scholar
  29. Thigpen T, Brady MF, Homesley HD, et al. Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol. 2001;19:364.PubMedGoogle Scholar
  30. Trimble CL, Kauderer J, Zaino R, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia. Cancer. 2006;106(4):812–9. doi:10.1002/cncr.21650.CrossRefPubMedGoogle Scholar
  31. Trimble CL, Method M, Leitao M, et al. Management of endometrial precancers. Obstet Gynecol. 2012;120(5):1160. doi:10.1097/AOG.0b013e31826bb121.PubMedPubMedCentralGoogle Scholar
  32. Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, Barakat R, Pearl ML, Sharma SK. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. J Clin Oncol. 2012;30(13):695–700.CrossRefPubMedPubMedCentralGoogle Scholar
  33. Wright JD, Buck AM, Shah M, Burke WM, Schiff PB, Herzog TJ. Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin Oncol. 2009;27(8):1214–9.CrossRefPubMedGoogle Scholar
  34. Zullo F, Falbo A, Palomba S. Safety of laparoscopy vs laparotomy in the surgical staging of endometrial cancer: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol. 2012;207(2):94–100.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Division of Gynecologic Oncology, Department of Obstetrics and GynecologyUniversity of Florida College of Medicine JacksonvilleJacksonvilleUSA
  2. 2.Florida State College at JacksonvilleJacksonvilleUSA

Personalised recommendations